Comprehensive Analysis of Risk Factors for Pediatric Cancers Using the Utah Population Database |
Huntsman Cancer Institute / Joshua Schiffman, MD |
Epidemiology Grants |
2010 |
Utah |
Identification of predisposition genes for Ewing sarcoma segregating in high-risk pedigrees |
Huntsman Cancer Institute / Lisa Cannon-Albright, PhD |
Innovation Grants |
2012 |
Utah |
Determining Social Risk Factors for Poor Outcomes in Pediatric Cancer Using Children’s Oncology Group Registries |
University of Utah / Anne Kirchhoff, PhD/MPH |
Epidemiology Grants |
2019 |
Utah |
Targeting Metabolism in Alveolar Soft Part Sarcomagenesis |
Huntsman Cancer Institute / Kevin Jones, MD |
'A' Award Grants |
2013 |
Utah |
Relationships Between Symptoms and the Hospital Care Environment in Children and Adolescents with Cancer |
Huntsman Cancer Institute / Lauri Linder |
Nurse Researcher Grants |
2010 |
Utah |
LSD1 Inhibition to Treat T-cell Acute Lymphoblastic Leukemia/Lymphoma |
University of Virginia, School of Medicine / Michael Engel, MD/PhD |
Reach Grants |
2016 |
Virginia |
Small Molecule Inhibitors of ERG for Pediatric Leukemia and Sarcoma |
University of Virginia, School of Medicine / John Bushweller, PhD |
Innovation Grants |
2015 |
Virginia |
Pharmacogenomics and Drug Screening Lead to a Novel Targeted Therapy with Potent and Specific Activity Against Mouse Models of MYCN-amplified Neuroblastoma |
Virginia Commonwealth University / Anthony Faber, MD & Yael Mosse, MD (CHOP) |
Innovation Grants |
2015 |
Virginia |
TrkB Signaling in the Genesis of Murine Neuroblastoma
|
University of Vermont / Rae Nishi, PhD |
Innovation Grants |
2007 |
Vermont |
Critical Contributions of CRM1 to Leukemogenesis |
University of Vermont / Jessica Linda Heath, MD |
Young Investigator Grants |
2015 |
Vermont |